Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Validating a generic cancer consumer quality index in eight European countries, patient reported experiences and the influence of cultural differences

A. Wind, ED. Hartman, RRJP. Van Eekeren, RPWF. Wijn, J. Halámková, J. Mattson, S. Siesling, WH. van Harten

. 2021 ; 21 (1) : 231. [pub] 20210306

Language English Country Great Britain

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc21019084

BACKGROUND: Taking patient centeredness into account is important in healthcare. The European Cancer Consumer Quality Index (ECCQI) is a validated tool for international benchmarking of patient experiences and satisfaction. This study aimed to further validate the ECCQI in larger and more uniform groups of high volume tumours such as breast and prostate cancer. A second objective was the verification of the influence of cultural factors of the country to determine its possible use in international benchmarking. METHODS: Data from two survey studies in eight European countries were combined. Socio-demographic correlations were analysed with Kruskall-Wallis and Mann-Whitney tests. Cronbach's alpha was calculated to validate internal consistency. Influences of masculinity (MAS), power distance (PD) and uncertainty avoidance (UA) were determined by linear regression analysis in a general model and subgroup models. RESULTS: A total of 1322 surveys were included in the analysis (1093 breast- and 348 prostate cancer patients). Cronbach's alpha was good (α ≥ 0.7) or acceptable (0.5 ≤ α ≤ 0.7) in 8 out of 9 questionnaire categories, except in the category 'Safety' (α = 0.305). Overall ECCQI scores ranged from 22.1 to 25.1 between countries on a 1-35 scale (categories had a 1-4 scale). In certain subcategories such as 'Organisation' (range 2.2 vs 3.0) and 'Supervision & Support' (range 3.0 vs 3.8) a large difference was observed between countries. Differences in 'Overall opinion' were however small: mean scores of 3.7 vs 3.9, whereas median scores were all the maximum of 4.0. Power distance was positively associated with higher patient satisfaction scores whereas Uncertainty avoidance was negatively associated with these scores. Masculinity was only associated with patient satisfaction scores in lower educated patients. We found the highest impact of culture on overall scores in Hungary and Portugal and the lowest in Romania. CONCLUSIONS: The ECCQI shows high internal consistency in all categories except 'Safety'. Especially in separate categories and overall ECCQI scores the questionnaire showed discriminative value. This study showed a positive correlation of power distance and a negative correlation for uncertainty avoidance in some countries. When using the ECCQI for international benchmarking these two dimensions of culture should be taken into account.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21019084
003      
CZ-PrNML
005      
20210830100648.0
007      
ta
008      
210728s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12885-021-07943-0 $2 doi
035    __
$a (PubMed)33676435
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Wind, A $u Rijnstate Hospital, Arnhem, The Netherlands. ankewind@gmail.com
245    10
$a Validating a generic cancer consumer quality index in eight European countries, patient reported experiences and the influence of cultural differences / $c A. Wind, ED. Hartman, RRJP. Van Eekeren, RPWF. Wijn, J. Halámková, J. Mattson, S. Siesling, WH. van Harten
520    9_
$a BACKGROUND: Taking patient centeredness into account is important in healthcare. The European Cancer Consumer Quality Index (ECCQI) is a validated tool for international benchmarking of patient experiences and satisfaction. This study aimed to further validate the ECCQI in larger and more uniform groups of high volume tumours such as breast and prostate cancer. A second objective was the verification of the influence of cultural factors of the country to determine its possible use in international benchmarking. METHODS: Data from two survey studies in eight European countries were combined. Socio-demographic correlations were analysed with Kruskall-Wallis and Mann-Whitney tests. Cronbach's alpha was calculated to validate internal consistency. Influences of masculinity (MAS), power distance (PD) and uncertainty avoidance (UA) were determined by linear regression analysis in a general model and subgroup models. RESULTS: A total of 1322 surveys were included in the analysis (1093 breast- and 348 prostate cancer patients). Cronbach's alpha was good (α ≥ 0.7) or acceptable (0.5 ≤ α ≤ 0.7) in 8 out of 9 questionnaire categories, except in the category 'Safety' (α = 0.305). Overall ECCQI scores ranged from 22.1 to 25.1 between countries on a 1-35 scale (categories had a 1-4 scale). In certain subcategories such as 'Organisation' (range 2.2 vs 3.0) and 'Supervision & Support' (range 3.0 vs 3.8) a large difference was observed between countries. Differences in 'Overall opinion' were however small: mean scores of 3.7 vs 3.9, whereas median scores were all the maximum of 4.0. Power distance was positively associated with higher patient satisfaction scores whereas Uncertainty avoidance was negatively associated with these scores. Masculinity was only associated with patient satisfaction scores in lower educated patients. We found the highest impact of culture on overall scores in Hungary and Portugal and the lowest in Romania. CONCLUSIONS: The ECCQI shows high internal consistency in all categories except 'Safety'. Especially in separate categories and overall ECCQI scores the questionnaire showed discriminative value. This study showed a positive correlation of power distance and a negative correlation for uncertainty avoidance in some countries. When using the ECCQI for international benchmarking these two dimensions of culture should be taken into account.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a benchmarking $x statistika a číselné údaje $7 D019985
650    _2
$a nádory prsu $x psychologie $x terapie $7 D001943
650    _2
$a přežívající onkologičtí pacienti $x psychologie $x statistika a číselné údaje $7 D000073116
650    12
$a srovnání kultur $7 D003431
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    12
$a hodnocení výsledků péče pacientem $7 D000071066
650    _2
$a bezpečnost pacientů $x statistika a číselné údaje $7 D061214
650    _2
$a spokojenost pacientů $x statistika a číselné údaje $7 D017060
650    _2
$a nádory prostaty $x psychologie $x terapie $7 D011471
650    _2
$a reprodukovatelnost výsledků $7 D015203
650    _2
$a nejistota $7 D035501
650    _2
$a mladý dospělý $7 D055815
651    _2
$a Evropa $7 D005060
655    _2
$a časopisecké články $7 D016428
700    1_
$a Hartman, E D $u Rijnstate Hospital, Arnhem, The Netherlands $u Department of Health Technology and Services Research, technical Medical Centre, Faculty of behavioural, management and social sciences (BMS), University of Twente, Enschede, The Netherlands
700    1_
$a Van Eekeren, R R J P $u Rijnstate Hospital, Arnhem, The Netherlands
700    1_
$a Wijn, R P W F $u Departement of Urology, Jeroen Bosch Hospital, Den Bosch, The Netherlands
700    1_
$a Halámková, J $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic $u Department of Comprehensive Cancer Care, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Mattson, J $u Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
700    1_
$a Siesling, S $u Department of Health Technology and Services Research, technical Medical Centre, Faculty of behavioural, management and social sciences (BMS), University of Twente, Enschede, The Netherlands $u Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands
700    1_
$a van Harten, W H $u Rijnstate Hospital, Arnhem, The Netherlands $u Department of Health Technology and Services Research, technical Medical Centre, Faculty of behavioural, management and social sciences (BMS), University of Twente, Enschede, The Netherlands
773    0_
$w MED00008171 $t BMC cancer $x 1471-2407 $g Roč. 21, č. 1 (2021), s. 231
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33676435 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830100648 $b ABA008
999    __
$a ok $b bmc $g 1690004 $s 1139530
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 21 $c 1 $d 231 $e 20210306 $i 1471-2407 $m BMC cancer $n BMC Cancer $x MED00008171
LZP    __
$a Pubmed-20210728

Find record

Citation metrics

Archiving options